CSGALNACT2-SLC16A9 Fusion FISH Probe
The CSGALNACT2-SLC16A9 Fusion FISH Probe is used to confirm a fusion of the CSGALNACT2 and SLC16A9 genes. The fusion of the CSGALNACT2 and SLC16A9 genes has been associated with Thyroid Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| CSGALNACT2-SLC16A9-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| CSGALNACT2-SLC16A9-20-RERE | 20 (40 μL) | 200 μL |
|
|
| CSGALNACT2-SLC16A9-20-REOR | 20 (40 μL) | 200 μL |
|
|
| CSGALNACT2-SLC16A9-20-REGO | 20 (40 μL) | 200 μL |
|
|
| CSGALNACT2-SLC16A9-20-REGR | 20 (40 μL) | 200 μL |
|
|
| CSGALNACT2-SLC16A9-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| CSGALNACT2-SLC16A9-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| CSGALNACT2-SLC16A9-20-OROR | 20 (40 μL) | 200 μL |
|
|
| CSGALNACT2-SLC16A9-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| CSGALNACT2-SLC16A9-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| CSGALNACT2-SLC16A9-20-GORE | 20 (40 μL) | 200 μL |
|
|
| CSGALNACT2-SLC16A9-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| CSGALNACT2-SLC16A9-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| CSGALNACT2-SLC16A9-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| CSGALNACT2-SLC16A9-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| CSGALNACT2-SLC16A9-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| CSGALNACT2-SLC16A9-20-GROR | 20 (40 μL) | 200 μL |
|
|
| CSGALNACT2-SLC16A9-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| CSGALNACT2-SLC16A9-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| CSGALNACT2-SLC16A9-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| CSGALNACT2-SLC16A9-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| CSGALNACT2-SLC16A9-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| CSGALNACT2-SLC16A9-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| CSGALNACT2-SLC16A9-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| CSGALNACT2-SLC16A9-20-AQAQ | 20 (40 μL) | 200 μL |
|
CSGALNACT2 Gene Summary
This gene encodes a member of the chondroitin N-acetylgalactosaminyltransferase family. The encoded protein is involved in elongation during chondroitin sulfate synthesis. Alternative splicing of this gene results in multiple transcript variants. Two related pseudogenes have been identified on chromosome X. [provided by RefSeq, Feb 2016]
Gene Name: Chondroitin Sulfate N-acetylgalactosaminyltransferase 2
Chromosome: CHR10: 43633933 -43680749
Locus: 10q11.21
SLC16A9 Gene Summary
The Solute Carrier Family 16 Member 9 (SLC16A9) gene is located on chr10 :61410521-61469649 at 10q21.2.
Gene Name: Solute Carrier Family 16 Member 9
Chromosome: CHR10: 61410521 -61469649
Locus: 10q21.2
Gene Diseases
The CSGALNACT2 SLC16A9 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Thyroid Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|